{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:17:16Z","timestamp":1791494236051,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T00:00:00Z","timestamp":1280275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11906-010-0134-2","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T06:36:55Z","timestamp":1280212615000},"page":"342-348","source":"Crossref","is-referenced-by-count":55,"title":["Prevalence and Diagnosis of Primary Aldosteronism"],"prefix":"10.1007","volume":"12","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"134_CR1","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW: Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955, 45:3\u201317.","journal-title":"J Lab Clin Med"},{"key":"134_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2006.07.003","volume":"20","author":"GP Rossi","year":"2006","unstructured":"Rossi GP: Surgically correctable hypertension caused by primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2006, 20:385\u2013400.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"134_CR3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0029-1243253","volume":"42","author":"N Schupp","year":"2010","unstructured":"\u2022 Schupp N, Queisser N, Wolf M, et al.: Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists. Horm Metab Res 2010, 42:458\u2013465. This study shows that aldosterone causes oxidative DNA damage, which could be prevented by MR antagonists.","journal-title":"Horm Metab Res"},{"key":"134_CR4","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha R, Rudolph AE, Frierdich GE, et al.: Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002, 283:H1802\u2013H1810.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl D","key":"134_CR5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurheartj\/13.suppl_D.24","volume":"13","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Maisch B, Weber KT: Myocardial collagen matrix remodelling in arterial hypertension. Eur Heart J 1992, 13(Suppl D):24\u201332.","journal-title":"Eur Heart J"},{"key":"134_CR6","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","volume":"95","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Sacchetto A, Pavan E, et al.: Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma. Circulation 1997, 95:1471\u20131478.","journal-title":"Circulation"},{"key":"134_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","volume":"40","author":"GP Rossi","year":"2002","unstructured":"Rossi GP, Di Bello V, Ganzaroli C, et al.: Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002, 40:23\u201327.","journal-title":"Hypertension"},{"key":"134_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","volume":"103","author":"CA Farquharson","year":"2002","unstructured":"Farquharson CA, Struthers AD: Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) 2002, 103:425\u2013431.","journal-title":"Clin Sci (Lond)"},{"key":"134_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0735-1097(98)00322-2","volume":"32","author":"D Rizzoni","year":"1998","unstructured":"Rizzoni D, Muiesan ML, Porteri E, et al.: Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 1998, 32:985\u2013992.","journal-title":"J Am Coll Cardiol"},{"key":"134_CR10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, et al.: Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 2006, 48:232\u2013238.","journal-title":"Hypertension"},{"key":"134_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","volume":"19","author":"GP Rossi","year":"2008","unstructured":"\u2022 Rossi GP, Sechi LA, Giacchetti G, et al.: Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008, 19:88\u201390. This review article provides updated information on the involvement of excess aldosterone in causing target organ damage in hypertension and in worsening the prognosis of patients with heart failure and post-MI patients.","journal-title":"Trends Endocrinol Metab"},{"key":"134_CR12","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, et al.: Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006, 295:2638\u20132645.","journal-title":"JAMA"},{"key":"134_CR13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, et al.: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45:1243\u20131248.","journal-title":"J Am Coll Cardiol"},{"key":"134_CR14","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","volume":"51","author":"GP Rossi","year":"2008","unstructured":"\u2022 Rossi GP, Bolognesi M, Rizzoni D, et al.: Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008, 51:1366\u20131371. This paper provides solid information on the effect of adrenalectomy on hyperaldosteronism and blood pressure when the patients are selected for adrenalectomy based on demonstration of lateralized aldosterone excess. It also identifies the predictors of the blood pressure outcome.","journal-title":"Hypertension"},{"key":"134_CR15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"\u2022 Catena C, Colussi G, Lapenna R, et al.: Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007, 50:911\u2013918. This paper provides information on the effects of adrenalectomy and treatment with MR antagonists on left ventricular mass index.","journal-title":"Hypertension"},{"key":"134_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","volume":"20","author":"RD Gordon","year":"1993","unstructured":"Gordon RD, Ziesak MD, Tunny TJ, et al.: Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993, 20:296\u2013298.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"134_CR17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson Jr","year":"1994","unstructured":"Anderson GH, Jr., Blakeman N, Streeten DH: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994, 12:609\u2013615.","journal-title":"J Hypertens"},{"key":"134_CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, et al.: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"134_CR19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.1998.00608.x","volume":"49","author":"GP Rossi","year":"1998","unstructured":"Rossi GP, Rossi E, Pavan E, et al. Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol (Oxf) 1998, 49:713\u2013723.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"134_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-004-0001-0","volume":"6","author":"GP Rossi","year":"2004","unstructured":"Rossi GP: Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue? Curr Hypertens Rep 2004, 6:1\u20134.","journal-title":"Curr Hypertens Rep"},{"key":"134_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","volume":"26","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Pessina AC, Heagerty AM: Primary aldosteronism: an update on screening, diagnosis and treatment. J Hypertens 2008, 26:613\u2013621.","journal-title":"J Hypertens"},{"key":"134_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360600931831","volume":"44","author":"GP Rossi","year":"2007","unstructured":"\u2022 Rossi GP, Seccia TM, Pessina AC: Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 2007, 44:1\u201385. This review article provides updated information on laboratory tests, including the renin and aldosterone assay, for identifying the secondary forms of arterial hypertension.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"134_CR23","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, et al.: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008, 93:3266\u20133281.","journal-title":"J Clin Endocrinol Metab"},{"key":"134_CR24","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, et al.: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006, 48:2293\u20132300.","journal-title":"J Am Coll Cardiol"},{"key":"134_CR25","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1210\/jc.2008-0251","volume":"93","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Belfiore A, Bernini G, et al.: Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab 2008, 93:2566\u20132571.","journal-title":"J Clin Endocrinol Metab"},{"key":"134_CR26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","volume":"16","author":"JE Sealey","year":"2005","unstructured":"Sealey JE, Gordon RD, Mantero F: Plasma renin and aldosterone measurements in low renin hypertensive states. Trends Endocrinol Metab 2005, 16:86\u201391.","journal-title":"Trends Endocrinol Metab"},{"key":"134_CR27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","volume":"55","author":"DJ Campbell","year":"2009","unstructured":"Campbell DJ, Nussberger J, Stowasser M, et al.: Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009, 55:867\u2013877.","journal-title":"Clin Chem"},{"key":"134_CR28","doi-asserted-by":"crossref","unstructured":"\u2022 Rossi GP, Barisa M, Belfiore A, et al.: The aldosterone renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens 2010 (in press). This paper provides information on the performance of the direct renin assay as compared with the plasma renin assay for the identification of APA.","DOI":"10.1097\/HJH.0b013e32833d2192"},{"key":"134_CR29","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","volume":"21","author":"M Stowasser","year":"2003","unstructured":"Stowasser M, Gordon RD, Gunasekera TG, et al.: High rate of detection of primary aldosteronism, including surgically treatable forms, after \u201cnon-selective\u201d screening of hypertensive patients. J Hypertens 2003, 21:2149\u20132157.","journal-title":"J Hypertens"},{"key":"134_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","volume":"55","author":"GP Rossi","year":"2010","unstructured":"\u2022 Rossi GP, Seccia TM, Palumbo G, et al.: Within-patient reproducibility of the aldosterone:renin ratio in primary aldosteronism. Hypertension 2010, 55:83\u201389. This paper investigated the reproducibility of the ARR when repeated in the same patients under standardized conditions.","journal-title":"Hypertension"},{"key":"134_CR31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajh\/3.7.576","volume":"3","author":"I Irony","year":"1990","unstructured":"Irony I, Kater CE, Biglieri EG, Shackleton CH: Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens 1990, 3:576\u2013582.","journal-title":"Am J Hypertens"},{"issue":"Suppl 5","key":"134_CR32","first-page":"S103","volume":"5","author":"RD Gordon","year":"1987","unstructured":"Gordon RD, Gomez-Sanchez CE, Hamlet SM, et al.: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin hypertension. J Hypertens Suppl 1987, 5(Suppl 5):S103\u2013S106.","journal-title":"J Hypertens Suppl"},{"key":"134_CR33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"\u2022 Rossi GP, Belfiore A, Bernini G, et al.: Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007, 50:424\u2013431. This study compared head-to-head the captopril and the saline infusion tests for excluding APA under different sodium intakes.","journal-title":"Hypertension"},{"key":"134_CR34","first-page":"357","volume":"7","author":"GP Rossi","year":"1993","unstructured":"Rossi GP, Chiesura-Corona M, Tregnaghi A, et al.: Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J Hum Hypertens 1993, 7:357\u2013363.","journal-title":"J Hum Hypertens"},{"key":"134_CR35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(00)03129-9","volume":"356","author":"GP Rossi","year":"2000","unstructured":"Rossi GP, Vendraminelli R, Cesari M, Pessina AC: A thoracic mass with hypertension and hypokalaemia [case report]. Lancet 2000, 356:1570.","journal-title":"Lancet"},{"key":"134_CR36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","volume":"12","author":"TM Seccia","year":"2005","unstructured":"Seccia TM, Fassina A, Nussdorfer GG, et al.: Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn\u2019s syndrome with an ominous clinical course. Endocr Relat Cancer 2005, 12:149\u2013159.","journal-title":"Endocr Relat Cancer"},{"key":"134_CR37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/meta.2002.30498","volume":"51","author":"M Omura","year":"2002","unstructured":"Omura M, Sasano H, Fujiwara T, et al.: Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 2002, 51:350\u2013355.","journal-title":"Metabolism"},{"key":"134_CR38","first-page":"1066","volume":"86","author":"SB Magill","year":"2001","unstructured":"Magill SB, Raff H, Shaker JL, et al.: Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab 2001, 86:1066\u20131071.","journal-title":"J Clin Endocrinol Metab"},{"key":"134_CR39","first-page":"637","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G, et al.: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000, 85:637\u2013644.","journal-title":"J Clin Endocrinol Metab"},{"key":"134_CR40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, et al.: Role for adrenal venous sampling in primary aldosteronism. Surgery 2004, 136:1227\u20131235.","journal-title":"Surgery"},{"key":"134_CR41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"\u2022 Kempers MJ, Lenders JW, van Outheusden L, et al.: Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 2009, 151:329\u2013337. This study is a meta-analysis of different procedures used for differentiation of PA subtypes.","journal-title":"Ann Intern Med"},{"key":"134_CR42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11906-007-0017-3","volume":"9","author":"GP Rossi","year":"2007","unstructured":"Rossi GP: New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Curr Hypertens Rep 2007, 9:90\u201397.","journal-title":"Curr Hypertens Rep"},{"key":"134_CR43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/HJH.0b013e3282f9e66a","volume":"26","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Pitter G, Bernante P, et al.: Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008, 26:989\u2013997.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"134_CR44","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1148\/rg.25si055514","volume":"25","author":"N Daunt","year":"2005","unstructured":"Daunt N: Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics 2005, 25(Suppl 1):S143\u2013S158.","journal-title":"Radiographics"},{"key":"134_CR45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","volume":"86","author":"GP Rossi","year":"2001","unstructured":"Rossi GP, Sacchetto A, Chiesura-Corona M, et al.: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001, 86:1083\u20131090.","journal-title":"J Clin Endocrinol Metab"},{"key":"134_CR46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.hjh.0000202818.10459.96","volume":"24","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Ganzaroli C, Miotto D, et al.: Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 2006, 24:371\u2013379.","journal-title":"J Hypertens"},{"key":"134_CR47","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/HJH.0b013e3281c4a006","volume":"25","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Pitter G, Miotto D: To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not? Round 2. J Hypertens 2007, 25:1518\u20131520.","journal-title":"J Hypertens"},{"key":"134_CR48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","volume":"53","author":"TM Seccia","year":"2009","unstructured":"Seccia TM, Miotto D, De Toni R, et al.: Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 2009, 53:761\u2013766.","journal-title":"Hypertension"},{"key":"134_CR49","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.109.134759","volume":"54","author":"D Miotto","year":"2009","unstructured":"\u2022 Miotto D, De Toni R, Pitter G, et al.: Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension 2009, 54:885\u2013889. This study described the impact of the presence of accessory hepatic veins on the right side on the results of AVS and highlighted the importance of superselective catheterization when such variants are identified.","journal-title":"Hypertension"},{"key":"134_CR50","first-page":"503","volume":"1","author":"A Toniato","year":"2000","unstructured":"Toniato A, Bernante P, Rossi GP, et al.: Laparoscopic versus open adrenalectomy: outcome in 35 consecutive patients. Int J Surg Investig 2000, 1:503\u2013507.","journal-title":"Int J Surg Investig"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-010-0134-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-010-0134-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-010-0134-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:25Z","timestamp":1559434465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-010-0134-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s11906-010-0134-2","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,28]]}}}